$3.39-0.40 (-10.55%)
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
Universe Pharmaceuticals INC in the Healthcare sector is trading at $3.39 with a market capitalization of $2M. The stock is currently near its 52-week low of $2.00, remaining 10.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 19 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|
| Total Revenue | β | β | β | β | β |
| Gross Profit | β | β | β | β | β |
| Operating Income | β | β | β | β | β |
| Net Income | β | β | β | β | β |
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common ...